Object Details
maker
Genentech, Inc.
Novartis Vaccines and Diagnostics Limited
Description (Brief)
(From box)
For subcutaneous use
(From insert)
Xolair is indicated for:
-Moderate to severe persistent asthma in patients with a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with inhaled corticosteroids.
Important Limitations of use:
-Not indicated for other allergic conditions
-Not indicated for acute bronchospasm or status asthmaticus
-Not indicated for pediatric patients less than 12 years of age
Location
Currently not on view
Credit Line
Gift of Genentech, Inc.
date made
ca 2013
product expiration date
2016-08
ID Number
2013.0069.13
catalog number
2013.0069.13
accession number
2013.0069
Object Name
pharmaceutical
biological
Physical Description
glass (overall material)
metal (overall material)
plastic (overall material)
paper (overall material)
cardboard (overall material)
Omalizumab, 150mg (overall ingredient)
Measurements
overall: 1 in x 2 1/8 in x 3 3/8 in; 2.54 cm x 5.3975 cm x 8.5725 cm
bottle of sterile water for injection: 2 3/16 in x 1 in; 5.55625 cm x 2.54 cm
10ml syringe: 1 7/8 in x 8 1/4 in x 3/4 in; 4.7625 cm x 20.955 cm x 1.905 cm
alcohol wipe: 2 in x 2 in; 5.08 cm x 5.08 cm
overall: 3 3/8 in x 2 in x 1 in; 8.5725 cm x 5.08 cm x 2.54 cm
place made
United States: California, South San Francisco
Switzerland
See more items in
Medicine and Science: Medicine
Health & Medicine
The Antibody Initiative
Antibody Initiative: Monoclonal Antibodies
Data Source
National Museum of American History
Link to Original Record
Record ID
nmah_1445213